CALICHEAMICINS, A NOVEL FAMILY OF ANTITUMOR ANTIBIOTICS .4. STRUCTURE ELUCIDATION OF CALICHEAMICINS BETA-1BR, GAMMA-1BR, ALPHA-2I, ALPHA-3I, BETA-1I, GAMMA-1I, AND DELTA-1I

被引:131
作者
LEE, MD
DUNNE, TS
CHANG, CC
SIEGEL, MM
MORTON, GO
ELLESTAD, GA
MCGAHREN, WJ
BORDERS, DB
机构
[1] American Cyanamid Company, Medical Research Division, Lederle Laboratories, New York 10965, Pearl River
关键词
D O I
10.1021/ja00029a030
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The details of the structural assignment of the potent antitumor antibiotic, calicheamicin gamma-1I (6, C55H74IN3O21S4), is reported. Methanolysis studies on 6 and N-acetylcalicheamicin gamma-1I (8, C57H76IN3022S4) permitted the structural assignment of the glycosidic chain. Details of the spectral analysis supporting the assignments of the 3-O-methyl-alpha-L-rhamnopyranoside (D-ring) and the methyl 2,4-dideoxy-3-O-methyl-4-(N-acetyl-N-ethylamino)-a-L-xylopyranoside (E-ring) is reported. The structure of calicheamicinone (32, C18H17NO5S3), containing a bicyclo[7.3.1 ] tridec-9-ene-2,6-diyne system and a methyl trisulfide, was elucidated by a series of chemical degradation studies, which included an unexpected free radical cycloaromatization reaction. The presence of 4,6-dideoxy-4-(hydroxyamino)-beta-D-glucopyranoside (A-ring) and its N-O glycosidic linkage to the thio sugar (B-ring) was ascertained by X-ray crystallography of 24 (C36H40INO13S2), a degradation product of 6. The chemical structures of calicheamicins beta-1Br (1), gamma-1Br (2), alpha-2I (3), alpha-3I (4), beta-1I (5), and delta-1I (7) were assigned by correlating their H-1 and C-13 NMR data with that of calicheamicin gamma-1I. By tracking the biological activities of the degradation products, the enediyne system of calicheamicinone was shown to be essential for the DNA-damaging abilities of the calicheamicins. A mechanism whereby the enediyne could be triggered to cyclize via a 1,4-diyl, the putative DNA cleaving species, is proposed.
引用
收藏
页码:985 / 997
页数:13
相关论文
共 57 条
[1]   ISOLATION OF LAVENDAMYCIN A NEW ANTIBIOTIC FROM STREPTOMYCES-LAVENDULAE [J].
BALITZ, DM ;
BUSH, JA ;
BRADNER, WT ;
DOYLE, TW ;
OHERRON, FA ;
NETTLETON, DE .
JOURNAL OF ANTIBIOTICS, 1982, 35 (03) :259-265
[2]   C-13 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY OF MONOSACCHARIDES [J].
BOCK, K ;
PEDERSEN, C .
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, 1983, 41 :27-66
[3]  
Bremser W., 1982, CHEM SHIFT RANGES CA
[4]   PD-114,759 AND PD-115,028, NOVEL ANTITUMOR ANTIBIOTICS WITH PHENOMENAL POTENCY .1. ISOLATION AND CHARACTERIZATION [J].
BUNGE, RH ;
HURLEY, TR ;
SMITKA, TA ;
WILLMER, NE ;
BRANKIEWICZ, AJ ;
STEINMAN, CE ;
FRENCH, JC .
JOURNAL OF ANTIBIOTICS, 1984, 37 (12) :1566-1571
[5]   LARGOMYCIN FII CHROMOPHORE COMPONENT-4, A NEW PLURAMYCIN ANTIBIOTIC [J].
BYRNE, KM ;
GONDA, SK ;
HILTON, BD .
JOURNAL OF ANTIBIOTICS, 1985, 38 (08) :1040-1049
[6]   CHARACTERIZATION OF THE INVITRO CYCLIZATION CHEMISTRY OF CALICHEAMICIN AND ITS RELATION TO DNA CLEAVAGE [J].
DEVOSS, JJ ;
HANGELAND, JJ ;
TOWNSEND, CA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (11) :4554-4556
[7]  
Elespuru R . K., 1979, ENV MUTAGEN, V1, P55
[8]  
ELESPURU RK, 1983, CANCER RES, V43, P2819
[9]   REACTIONS OF THE TRISULFIDE MOIETY IN CALICHEAMICIN [J].
ELLESTAD, GA ;
HAMANN, PR ;
ZEIN, N ;
MORTON, GO ;
SIEGEL, MM ;
PASTEL, M ;
BORDERS, DB ;
MCGAHREN, WJ .
TETRAHEDRON LETTERS, 1989, 30 (23) :3033-3036
[10]   STRUCTURE AND CHEMISTRY OF KIDAMYCIN [J].
FURUKAWA, M ;
HAYAKAWA, I ;
OHTA, G ;
IITAKA, Y .
TETRAHEDRON, 1975, 31 (23) :2989-2995